Clinical Trials on Melanoma, Stage II in Germany
Total 586 results
-
University Hospital, EssenActive, not recruitingMalignant Melanoma Stage IIGermany
-
University Hospital TuebingenUnknownMalignant Melanoma Stage IVGermany
-
Philogen S.p.A.Active, not recruiting
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
Dermatologic Cooperative Oncology GroupUnknownTherapy | Adjuvant | Stage III Malignant Melanoma | Interferon AlphaGermany
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
BioNTech SERegeneron PharmaceuticalsActive, not recruitingUnresectable Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, Italy, Australia, United Kingdom, Poland
-
University Hospital TuebingenCompletedLocoregional Metastases in Malignant Melanoma Stages IIIB/CGermany
-
Eisai Inc.Quintiles, Inc.CompletedStage IV MelanomaUnited Kingdom, United States, Spain, Germany, Italy
-
Eisai Inc.CompletedStage IV Melanoma | Unresectable Stage IIIUnited States, United Kingdom, Australia, Germany
-
European Organisation for Research and Treatment...Active, not recruitingStage IV Melanoma | Unresectable Stage III MelanomaFrance, Denmark, Spain, Finland, Italy, Germany, Poland, United Kingdom, Netherlands
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Hasumi International Research FoundationActive, not recruitingMelanoma, Uveal MetastaticGermany
-
AmgenCompletedUnresected Stage IIIb to IVM1c MelanomaFrance, Poland, Italy, Russian Federation, Netherlands, Spain, United States, Austria, Belgium, United Kingdom, Germany, Hungary, Greece
-
Heidelberg UniversityUniversity Hospital Tuebingen; SLK Kliniken Heilbronn GmbHUnknownStage IV Melanoma Patients With Unresectable Liver MetastasesGermany
-
Bristol-Myers SquibbCompleted
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
University Hospital TuebingenGerman Research FoundationCompleted
-
Charite University, Berlin, GermanyUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Heidelberg UniversityRoche Pharma AGActive, not recruitingStage II Grade 1 Follicular Lymphoma | Stage II Grade 2 Follicular Lymphoma | Stage I Follicular Lymphoma Grade 1 | Stage II Follicular Lymphoma Grade 2Germany
-
University Hospital TuebingenCompleted
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
University of RegensburgUnknown
-
Charite University, Berlin, GermanyUnknown
-
University of RegensburgClinAssess GmbHUnknown
-
OncoHost Ltd.RecruitingStage IV Non-small Cell Lung Cancer | Stage III Malignant Melanoma | Stage IV Small Cell Lung Cancer | Stage IV Malignant MelanomaUnited States, Israel, United Kingdom, Germany, Spain
-
Krankenhaus NordwestTerminatedChemo-refractory MelanomaGermany
-
Fachklinik Hornheide an der Universität MünsterWestfälische Wilhelms-Universität Münster; Deutsche RentenversicherungCompletedQuality of Life | Work Ability | Malignant Melanoma of SkinGermany
-
University Hospital ErlangenCompleted
-
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum...Unknown
-
European Organisation for Research and Treatment...Terminated
-
Ruhr University of BochumCompleted
-
University Hospital ErlangenCompleted
-
University Hospital ErlangenCompleted
-
University Hospital MuensterUnknown
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
University Hospital FreiburgUniversitätsklinikum Köln; Essex Pharma GmbHUnknownMalignant MelanomaGermany
-
Technische Universität DresdenTerminatedBrain Metastases | Malignant Melanoma Stage IV | BRAF V600 MutationGermany
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Philogen S.p.A.CompletedMalignant MelanomaAustria, Germany
-
Azienda Ospedaliera di PerugiaNot yet recruitingAdvanced Melanoma | Early MelanomaItaly, Sweden, France, Germany, Netherlands, Poland, Spain
-
Ruhr University of BochumCompletedCutaneous Malignant MelanomaGermany
-
Charite University, Berlin, GermanyUnknownUveal Melanoma | Exudative Retinal DetachmentGermany
-
University Hospital HeidelbergDietmar Hopp StiftungRecruitingNSCLC Stage IIIB | NSCLC Stage II | NSCLC, Stage IIIAGermany
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
Novo Nordisk A/STerminatedCancer | Malignant MelanomaGermany
-
University Hospital HeidelbergRecruitingEsophagus Cancer, Stage I | Esophagus Cancer, Stage IIGermany
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland